The Danish Health Authority approves the usage of the Molnupiravir antiviral pill developed by Merck & Co. for at-risk patients with symptoms, becoming the first EU country to authorize the usage of this drug. (NDTV) COVID-19 drug developmentCOVID-19 pandemic in DenmarkCOVID-19 pandemic in EuropeCOVID-19 pandemic link embed save